Ocular surface molecule after transconjunctival vitrectomy

British Journal of Ophthalmology

Volumn 95, Issue 3, 2011, Pages 419-423

  Fujita, Atsuko ^a   Uchino, Eisuke ^a   Otsuka, Hiroki ^a   Arimura, Noboru ^a   Noda, Yoshihiro ^b   Ishibashi, Tatsuro ^b   Sakamoto, Taiji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CONJUNCTIVA DISEASE; CONJUNCTIVA INFLAMMATION; CONTROLLED CLINICAL TRIAL; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EYE INFLAMMATION; FEMALE; HUMAN; INCISION; LACRIMAL FLUID LEVEL; MALE; OPERATION DURATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SEX DIFFERENCE; SURGICAL APPROACH; SUTURE; TRANSCONJUNCTIVAL PARS PLANA VITRECTOMY; VITRECTOMY; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CONJUNCTIVA; FEMALE; HUMANS; INTERLEUKIN-8; INTERLEUKINS; MALE; MIDDLE AGED; TEARS; TUMOR NECROSIS FACTOR-ALPHA; VISION, OCULAR; VITRECTOMY;

EID: 79952036878     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.185058     Document Type: Article

References (22)

1. Fujii GY, De Juan E Jr, Humayun MS, et al. A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology 2002;109:1807-12.
2. Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy. Retina 2005;25:208-11. (Pubitemid 40365946)
3. Fine HF, Iranmanesh R, Iturralde D, et al. Outcomes of 77 consecutive cases of 23-gauge transconjunctival vitrectomy surgery for posterior segment disease. Ophthalmology 2007;114:1197-200.
4. Williams GA. 25-, 23-, or 20-gauge instrumentation for vitreous surgery? Eye 2008;22:1263-6.
5. Rahman R, Rosen PH, Riddell C, et al. Self-sealing sclerotomies for sutureless pars plana vitrectomy. Ophthalmic Surg Lasers 2000;31:462-6.
6. Rizzo S, Genovesi-Ebert F, Belting C, et al. 25-gauge, sutureless vitrectomy and standard 20-gauge pars plana vitrectomy in idiopathic epiretinal membrane surgery: a comparative pilot study. Graefes Arch Clin Exp Ophthalmol 2006;244:472-9.
7. Kellner L, Wimpissinger B, Stolba U, et al. 25-gauge vs 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial. Br J Ophthalmol 2007;91:945-8. (Pubitemid 47013110)
8. Wimpissinger B, Kellner L, Brannath W, et al. 23-Gauge versus 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial. Br J Ophthalmol 2008;92:1483-7.
9. Wickham L, Bunce CS, Kwan AS, et al. A pilot randomised controlled trial comparing the post-operative pain experience following vitrectomy with a 20-gauge system and the 25-gauge transconjunctival system. Br J Ophthalmol 2010;36-40.
10. Uchino E, Sonoda S, Kinukawa N, et al. Alteration pattern of tear cytokines during the course of a day: diurnal rhythm analyzed by multicytokine assay. Cytokine 2006;33:36-40. (Pubitemid 43220350)
11. Sonoda S, Uchino E, Nakao K, et al. Inflammatory cytokine of basal and reflex tears analysed by multicytokine assay. Br J Ophthalmol 2006;90:120-2. (Pubitemid 43029915)
12. Yamakiri K, Sakamoto T, Noda Y, et al. Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology 2007;114:289-96.
13. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001;69:513-21. (Pubitemid 32294835)
14. Engelhardt E, Toksoy A, Goebeler M, et al. Chemokines IL-8, GROα, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998;153:1849-60. (Pubitemid 28550672)
15. Sooranna SR, Engineer N, Loudon JA, et al. The mitogen-activated protein kinase dependent expression of prostaglandin H synthase-2 and interleukin-8 messenger ribonucleic acid by myometrial cells: the differential effect of stretch and interleukin-1β. J Clin Endocrinol Metab 2005;90:3517-27. (Pubitemid 41014322)
16. Li LF, Ouyang B, Choukroun G, et al. Stretch-induced IL-8 depends on c-Jun NH2-terminal and nuclear factor-kappaB-inducing kinases. Am J Physiol Lung Cell Mol Physiol 2003;285:L464-75.
17. Iwaki M, Ito S, Morioka M, et al. Mechanical stretch enhances IL-8 production in pulmonary microvascular endothelial cells. Biochem Biophys Res Commun 2009;389:531-6.
18. Ricard JD, Dreyfuss D, Saumon G. Production of inflammatory cytokines in ventilator-induced lung injury: a reappraisal. Am J Respir Crit Care Med 2001;163:1176-80. (Pubitemid 32378457)
19. Barton K, Monroy DC, Nava A, et al. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology 1997;104:1868-74. (Pubitemid 28100344)
20. Lam H, Bleiden L, De Paiva CS, et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 2009;147:198-205.
21. Purokivi MK, Hirvonen MR, Randell JT, et al. Changes in pro-inflammatory cytokines in association with exposure to moisture-damaged building microbes. Eur Respir J 2001;18:951-8. (Pubitemid 34092868)
22. Dai X, Yamasaki K, Shirakata Y, et al. All-trans-retinoic acid induces interleukin-8 via the nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways in normal human keratinocytes. J Invest Dermatol 2004;123:1078-85. (Pubitemid 39586830)